# Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery

> **NCT04316936** · PHASE4 · COMPLETED · sponsor: **Silverstein Eye Centers** · enrollment: 15 (actual)

## Conditions studied

- Cataract Surgery

## Interventions

- **DRUG:** Omidria
- **DRUG:** Dextenza (dexamethasone ophthalmic insert) 0.4mg
- **DRUG:** Dexycu, 9% Intraocular Suspension
- **DRUG:** Prednisolone Acetate 1%

## Key facts

- **NCT ID:** NCT04316936
- **Lead sponsor:** Silverstein Eye Centers
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2020-12-23
- **Final completion:** 2020-12-23
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316936, "Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04316936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*